Xiamen Amoytop Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	936.64	553.16	371.82	412.96	301.24	285.42
Trading Asset Securities	150	462.48	289.96	257.08	270.78	196.38
Cash & Short-Term Investments	1,087	1,016	661.79	670.04	572.02	481.8
Cash Growth	32.82%	53.47%	-1.23%	17.14%	18.73%	3.53%
Accounts Receivable	1,157	1,244	808.52	441.02	223.05	206.28
Other Receivables	33.21	22.22	22.34	17.87	20.17	21.67
Receivables	1,190	1,266	830.86	458.9	243.22	227.94
Inventory	430.81	414.9	263.55	187.02	129.73	116.49
Other Current Assets	78.06	33.87	70.9	24.24	10.64	8.19
Total Current Assets	2,785	2,730	1,827	1,340	955.61	834.42
Property, Plant & Equipment	991.03	966.6	686.76	490.85	389.77	192.92
Goodwill	64.48	64.48	-	-	-	-
Other Intangible Assets	344.69	359.23	170.85	191.54	121.69	146.91
Long-Term Deferred Tax Assets	111.19	97.53	69.09	43.66	47.18	34.96
Long-Term Deferred Charges	66.89	63.39	221.2	176.7	229.25	169.14
Other Long-Term Assets	38.24	91.91	75.43	112.98	26.05	44.99
Total Assets	4,463	4,374	3,050	2,356	1,770	1,424
Accounts Payable	103.44	97.38	57.76	39.73	50.91	8.14
Accrued Expenses	144.14	288.37	233.75	244.46	159.55	120.4
Short-Term Debt	13.42	30.65	-	-	-	10
Current Portion of Long-Term Debt	15.22	6.09	-	-	-	-
Current Portion of Leases	-	10.74	5.67	4.16	4.18	5.79
Current Income Taxes Payable	84.11	91.28	50.27	48.95	41.97	24.42
Current Unearned Revenue	57.18	55.9	63.13	60.05	7.23	5.18
Other Current Liabilities	163.79	126.71	10.06	6.31	4.05	3.3
Total Current Liabilities	581.3	707.11	420.63	403.66	267.89	177.23
Long-Term Debt	135	104	-	-	-	-
Long-Term Leases	23.23	24.49	3.27	3.76	5.56	9.37
Long-Term Unearned Revenue	42.08	36.51	32.96	40.62	47.68	51.25
Long-Term Deferred Tax Liabilities	6.98	7.7	0.93	0.41	15.15	5.54
Other Long-Term Liabilities	44.42	44.13	39.31	31.25	25.99	19.53
Total Liabilities	833.02	923.94	497.1	479.69	362.27	262.91
Common Stock	408.19	408.19	406.8	406.8	406.8	406.8
Additional Paid-In Capital	545.31	528.99	413.14	397.04	397.04	397.04
Retained Earnings	2,677	2,512	1,733	1,073	603.76	357.42
Shareholders' Equity	3,630	3,450	2,553	1,876	1,408	1,161
Total Liabilities & Equity	4,463	4,374	3,050	2,356	1,770	1,424
Total Debt	186.88	175.97	8.94	7.92	9.74	25.16
Net Cash (Debt)	899.77	839.67	652.85	662.11	562.28	456.63
Net Cash Growth	12.48%	28.62%	-1.40%	17.76%	23.14%	2.28%
Net Cash Per Share	2.19	2.05	1.60	1.63	1.39	1.13
Filing Date Shares Outstanding	411.24	408.19	406.8	406.8	406.8	406.8
Total Common Shares Outstanding	411.24	408.19	406.8	406.8	406.8	406.8
Working Capital	2,204	2,023	1,406	936.53	687.72	657.19
Book Value Per Share	8.83	8.45	6.28	4.61	3.46	2.85
Tangible Book Value	3,221	3,026	2,382	1,685	1,286	1,014
Tangible Book Value Per Share	7.83	7.41	5.86	4.14	3.16	2.49
Buildings	-	491.9	291.61	135.53	118.65	21.31
Machinery	-	591.85	392.63	319.97	271.83	177.83
Construction In Progress	-	99.71	181.56	183.72	135.81	118

Source: S&P Global Market Intelligence. Standard template. Financial Sources.